Basis: Trailing twelve months (TTM), to the latest fiscal quarter end. Source: stored company filings and market data; unavailable inputs remain N/A.
Is the return on equity (ROE) high or low?
The return on equity (ROE) of -85.82% is 50% above its 3-year average of -171.90%, near the high end of its 3-year range (-346.39%–-77.03%).
As of the fiscal period ended Tuesday, June 30, 2026. 63.58% above its 12-month average of -235.61%.
Trailing-twelve-month return on equity at each fiscal quarter end; no daily interpolation. Q2 FY2026 (2026-06-30): -85.82%.
RETURN ON EQUITY (ROE)
-85.82%
RETURN ON EQUITY (ROE) AVG TTM
-235.61%
RETURN ON EQUITY (ROE) AVG 3Y
-179.19%
RETURN ON EQUITY (ROE) AVG 5Y
N/A
RETURN ON EQUITY (ROE) AVG 10Y
N/A
RETURN ON EQUITY (ROE) AVG 15Y
N/A
RETURN ON EQUITY (ROE) AVG 20Y
N/A
CURRENT VS TTM AVG
+63.58%
CURRENT VS 3Y AVG
+52.11%
CURRENT VS 5Y AVG
N/A
CURRENT VS 10Y AVG
N/A
CURRENT VS 15Y AVG
N/A
CURRENT VS 20Y AVG
N/A
SECTOR MEDIAN · HEALTHCARE
-42.01%
median of 754 covered companies
CURRENT VS SECTOR MEDIAN
-104.28%
vs the sector median at left
Bullfrog AI Holdings, Inc. Common Stock
Market Cap
$12.78M
Return on Equity (ROE)
-85.82%
TTM Avg
-235.61%
3Y Avg
-179.19%
5Y Avg
N/A
Market Cap
$12.58M
Return on Equity (ROE)
N/A
TTM Avg
-306.31%
3Y Avg
-229.99%
5Y Avg
-161.76%
Market Cap
$12.48M
Return on Equity (ROE)
N/A
TTM Avg
-201.97%
3Y Avg
-21.23%
5Y Avg
365.72%
Market Cap
$12.44M
Return on Equity (ROE)
N/A
TTM Avg
-162.71%
3Y Avg
-135.96%
5Y Avg
-98.83%
Market Cap
$13.11M
Return on Equity (ROE)
-810.41%
TTM Avg
-174.22%
3Y Avg
-126.94%
5Y Avg
-100.46%
Market Cap
$13.20M
Return on Equity (ROE)
-69.47%
TTM Avg
-55.64%
3Y Avg
-44.95%
5Y Avg
-41.56%
Market Cap
$13.30M
Return on Equity (ROE)
-39.76%
TTM Avg
-59.76%
3Y Avg
-51.18%
5Y Avg
-40.48%
Market Cap
$13.33M
Return on Equity (ROE)
-101.66%
TTM Avg
-140.38%
3Y Avg
-131.64%
5Y Avg
-101.94%
Market Cap
$12.17M
Return on Equity (ROE)
N/A
TTM Avg
-180.04%
3Y Avg
-6461.50%
5Y Avg
-4315.55%
| NAME | MARKET CAP | RETURN ON EQUITY (ROE) | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Bullfrog AI Holdings, Inc. Common Stock (BFRG) | $12.78M | -85.82% | -235.61% | -179.19% | N/A |
| Tempest Therapeutics, Inc. (TPST)vs › | $12.58M | N/A | -306.31% | -229.99% | -161.76% |
| Dare Bioscience, Inc. (DARE)vs › | $12.48M | N/A | -201.97% | -21.23% | 365.72% |
| Cytosorbents Corporation (CTSO)vs › | $12.44M | N/A | -162.71% | -135.96% | -98.83% |
| Passage Bio, Inc. (PASG)vs › | $13.11M | -810.41% | -174.22% | -126.94% | -100.46% |
| Citius Pharmaceuticals, Inc. (CTXR)vs › | $13.20M | -69.47% | -55.64% | -44.95% | -41.56% |
| Optimi Health Corp. (OPTH)vs › | $13.30M | -39.76% | -59.76% | -51.18% | -40.48% |
| IN8bio, Inc. (INAB)vs › | $13.33M | -101.66% | -140.38% | -131.64% | -101.94% |
| Lantern Pharma Inc. (LTRN)vs › | $12.17M | N/A | -180.04% | -6461.50% | -4315.55% |
| Cellectar Biosciences, Inc. (CLRB)vs › | $12.06M | -74.73% | -265.78% | -138.63% | -109.18% |
ROE
-85.8%
ROA
-77.9%
ROE = Net Income / Total Shareholders' Equity
Return on equity measures how efficiently a company generates profit from shareholders' equity. Higher ROE indicates better capital efficiency.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | RETURN ON EQUITY (ROE) |
|---|---|
| 2026-06-30 | -85.82% |
| 2026-03-31 | -124.29% |
| 2025-12-31 | -304.17% |
| 2025-09-30 | -346.39% |
| 2025-06-30 | -317.37% |
| 2025-03-31 | -218.93% |
| 2024-12-31 | -140.89% |
| 2024-09-30 | -172.00% |
| 2024-06-30 | -112.63% |
| 2024-03-31 | -87.21% |
| 2023-12-31 | -206.61% |
| 2023-09-30 | -126.15% |
| 2023-06-30 | -87.06% |
| 2023-03-31 | -77.03% |
